4.8 Article

Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1104423108

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan [17002015]
  2. Grants-in-Aid for Scientific Research [23659151, 22370042] Funding Source: KAKEN

向作者/读者索取更多资源

Activation-induced cytidine deaminase (AID) is shown to be essential and sufficient to induce two genetic alterations in the Ig loci: class switch recombination (CSR) and somatic hypermutation (SHM). However, it is still unknown how a single-molecule AID differentially regulates CSR and SHM. Here we identified Spt6 as an AID-interacting protein by yeast two-hybrid screening and immunoprecipitation followed by mass spectrometry. Knockdown of Spt6 resulted in severe reduction of CSR in both the endogenous Ig locus in B cells and an artificial substrate in fibroblast cells. Conversely, knockdown of Spt6 did not reduce but slightly enhanced SHM in an artificial substrate in B cells, indicating that Spt6 is required for AID to induce CSR but not SHM. These results suggest that Spt6 is involved in differential regulation of CSR and SHM by AID.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

The CCR4-NOT deadenylase complex controls Atg7-dependent cell death and heart function

Tomokazu Yamaguchi, Takashi Suzuki, Teruki Sato, Akinori Takahashi, Hiroyuki Watanabe, Ayumi Kadowaki, Miyuki Natsui, Hideaki Inagaki, Satoko Arakawa, Shinji Nakaoka, Yukio Koizumi, Shinsuke Seki, Shungo Adachi, Akira Fukao, Toshinobu Fujiwara, Tohru Natsume, Akinori Kimura, Masaaki Komatsu, Shigeomi Shimizu, Hiroshi Ito, Yutaka Suzuki, Josef M. Penninger, Tadashi Yamamoto, Yumiko Imai, Keiji Kuba

SCIENCE SIGNALING (2018)

Article Biochemistry & Molecular Biology

Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation

Takeo K. Maeda, Daisuke Sugiura, Il-mi Okazaki, Takumi Maruhashi, Taku Okazaki

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

PD-1 efficiently inhibits T cell activation even in the presence of co-stimulation through CD27 and GITR

Reina Mizuno, Takumi Maruhashi, Daisuke Sugiura, Kenji Shimizu, Mizuki Watada, Il-Mi Okazaki, Taku Okazaki

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses

Daisuke Sugiura, Takumi Maruhashi, Il-mi Okazaki, Kenji Shimizu, Takeo K. Maeda, Tatsuya Takemoto, Taku Okazaki

SCIENCE (2019)

Article Immunology

PD-1 aborts the activation trajectory of autoreactive CD8+ T cells to prohibit their acquisition of effector functions

Hikari Okamura, Il-mi Okazaki, Kenji Shimizu, Takumi Maruhashi, Daisuke Sugiura, Reina Mizuno, Taku Okazaki

JOURNAL OF AUTOIMMUNITY (2019)

Article Biochemistry & Molecular Biology

Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells

Natsumi Maeda, Takumi Maruhashi, Daisuke Sugiura, Kenji Shimizu, II-mi Okazaki, Taku Okazaki

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

PD-1 Imposes Qualitative Control of Cellular Transcriptomes in Response to T Cell Activation

Kenji Shimizu, Daisuke Sugiura, Il-mi Okazaki, Takumi Maruhashi, Yujiro Takegami, Chaoyang Cheng, Soichi Ozaki, Taku Okazaki

MOLECULAR CELL (2020)

Review Oncology

LAG-3: from molecular functions to clinical applications

Takumi Maruhashi, Daisuke Sugiura, Il-mi Okazaki, Taku Okazaki

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Multidisciplinary Sciences

PD-1 preferentially inhibits the activation of low-affinity T cells

Kenji Shimizu, Daisuke Sugiura, Il-mi Okazaki, Takumi Maruhashi, Tatsuya Takemoto, Taku Okazaki

Summary: PD-1 preferentially inhibits the expression of TCR-inducible genes when TCR:pMHC affinity is low, demonstrating a qualitative control of T cell responses by suppressing low-affinity T cells. Peptide-MHC affinities and MHC expression levels do not affect PD-1 sensitivity, suggesting that the strength of individual TCR signal is the key determinant of PD-1 sensitivity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity

Daisuke Sugiura, Il-mi Okazaki, Takeo K. Maeda, Takumi Maruhashi, Kenji Shimizu, Rieko Arakaki, Tatsuya Takemoto, Naozumi Ishimaru, Taku Okazaki

Summary: The study presents a method to enhance PD-1 function by targeting the PD-L1-CD80 duplex and demonstrates its effectiveness in alleviating symptoms of autoimmune diseases.

NATURE IMMUNOLOGY (2022)

Article Immunology

Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity

Takumi Maruhashi, Daisuke Sugiura, Il-Mi Okazaki, Kenji Shimizu, Takeo K. Maeda, Jun Ikubo, Harunori Yoshikawa, Katsumi Maenaka, Naozumi Ishimaru, Hidetaka Kosako, Tatsuya Takemoto, Taku Okazaki

Summary: The study identified stable pMHCII as a functional ligand of LAG-3 in both autoimmune and anti-cancer immunity, playing a crucial role in the suppressive activity of LAG-3.

IMMUNITY (2022)

Article Multidisciplinary Sciences

HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function

Yosuke Mitani, Shinya Ohashi, Osamu Kikuchi, Yukie Nakai, Tomomi Ida, Ayaka Mizumoto, Yoshihiro Yamamoto, Tomoki Saito, Shigeki Kataoka, Junichi Matsubara, Atsushi Yamada, Masashi Kanai, Shigemi Matsumoto, Hiroaki Sakai, Kiyotsugu Yoshikawa, Eijiro Nakamura, Manabu Muto

Summary: Clinical cancer genome sequencing can detect potential targets for cancer treatment and variants of unknown significance. This study found that a HER2 mutation in colorectal cancer has oncogenic potential when accompanied by loss of APC function. The findings suggest that this HER2 mutation may be a potential therapeutic target for colorectal cancer.

SCIENTIFIC REPORTS (2022)

Article Cell Biology

Role of Cancer Stem-like Cells in the Process of Invasion and Mesenchymal Transformation by a Reconstituted Triple-negative Breast Cancer Cell Population Resistant to p53-induced Apoptosis

Sana Inoue, Miki Imanishi, Ai Kanzaki, Atsumi Fujimoto, Marina Maeyama, Ayaka Okamoto, Hiroka Matsuda, Kiyotsugu Yoshikawa, Rei Takahashi

Summary: The role of cancer stem cells in apoptosis-resistant triple-negative breast cancer cells was investigated. The study revealed that these cells exhibit increased migration ability and up-regulated expression of transition-related genes.

ACTA HISTOCHEMICA ET CYTOCHEMICA (2022)

Review Immunology

T-cell-intrinsic and -extrinsic regulation of PD-1 function

Daisuke Sugiura, Kenji Shimizu, Takumi Maruhashi, Il-mi Okazaki, Taku Okazaki

Summary: PD-1 functions are strictly restricted during T-cell activation by the cis-interactions of PD-L1 and CD80, crucial for optimal T-cell responses. Sensitivity to PD-1 effects in T cells is essentially determined by intrinsic factors.

INTERNATIONAL IMMUNOLOGY (2021)

Article Immunology

PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation

Reina Mizuno, Daisuke Sugiura, Kenji Shimizu, Takumi Maruhashi, Mizuki Watada, Il-mi Okazaki, Taku Okazaki

FRONTIERS IN IMMUNOLOGY (2019)

暂无数据